Labcorp Long Term Debt 2010-2024 | LH

Labcorp long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.
  • Labcorp long term debt for the quarter ending September 30, 2024 was $5.427B, a 20.4% increase year-over-year.
  • Labcorp long term debt for 2023 was $4.133B, a 19.31% decline from 2022.
  • Labcorp long term debt for 2022 was $5.122B, a 6.88% decline from 2021.
  • Labcorp long term debt for 2021 was $5.501B, a 0.04% decline from 2020.
Labcorp Annual Long Term Debt
(Millions of US $)
2023 $4,133
2022 $5,122
2021 $5,501
2020 $5,503
2019 $5,881
2018 $6,042
2017 $6,345
2016 $5,300
2015 $5,940
2014 $2,683
2013 $2,889
2012 $2,175
2011 $2,086
2010 $1,827
2009 $977
Labcorp Quarterly Long Term Debt
(Millions of US $)
2024-09-30 $5,427
2024-06-30 $3,124
2024-03-31 $3,125
2023-12-31 $4,133
2023-09-30 $4,508
2023-06-30 $5,124
2023-03-31 $5,134
2022-12-31 $5,122
2022-09-30 $5,420
2022-06-30 $5,442
2022-03-31 $5,467
2021-12-31 $5,501
2021-09-30 $5,503
2021-06-30 $5,510
2021-03-31 $5,004
2020-12-31 $5,503
2020-09-30 $5,504
2020-06-30 $5,504
2020-03-31 $5,880
2019-12-31 $5,881
2019-09-30 $6,194
2019-06-30 $6,181
2019-03-31 $5,544
2018-12-31 $6,042
2018-09-30 $6,045
2018-06-30 $6,039
2018-03-31 $6,359
2017-12-31 $6,345
2017-09-30 $7,200
2017-06-30 $5,608
2017-03-31 $5,402
2016-12-31 $5,300
2016-09-30 $5,473
2016-06-30 $5,968
2016-03-31 $5,970
2015-12-31 $5,940
2015-09-30 $6,007
2015-06-30 $6,113
2015-03-31 $6,598
2014-12-31 $2,683
2014-09-30 $2,917
2014-06-30 $2,910
2014-03-31 $2,903
2013-12-31 $2,889
2013-09-30 $2,554
2013-06-30 $2,390
2013-03-31 $2,175
2012-12-31 $2,175
2012-09-30 $2,175
2012-06-30 $1,975
2012-03-31 $1,985
2011-12-31 $2,086
2011-09-30 $1,769
2011-06-30 $1,788
2011-03-31 $1,808
2010-12-31 $1,827
2010-09-30 $921
2010-06-30 $939
2010-03-31 $958
2009-12-31 $977
2009-09-30 $1,280
2009-06-30 $1,291
2009-03-31 $1,591
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $19.758B $12.162B
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.151B 21.33
Becton Dickinson (BDX) United States $64.352B 16.92
Cardinal Health (CAH) United States $28.637B 15.53
West Pharmaceutical Services (WST) United States $22.024B 44.99
Cooper (COO) United States $19.726B 28.08
Align Technology (ALGN) United States $16.616B 31.80
Henry Schein (HSIC) United States $9.331B 17.78
Merit Medical Systems (MMSI) United States $6.102B 31.16
DENTSPLY SIRONA (XRAY) United States $3.753B 10.20
CONMED (CNMD) United States $2.216B 18.49
Patterson (PDCO) United States $1.799B 9.49
STAAR Surgical (STAA) United States $1.288B 47.53
Lifevantage (LFVN) United States $0.170B 22.60
Pro-Dex (PDEX) United States $0.147B 29.36